Karl Martin Wissing

7PUBLICATIONS
7CO-AUTHORS
Haematological tumoursInnate immunityNutrigenomics and personalised nutritionGene and molecular therapyHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 07, 2026
Lanthanum carbonate does not reduce urinary oxalate excretion in hyperoxaluric kidney stone formers.

|May 11, 2022
Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis.

Arno Verleye, Veerle Wijtvliet, Steven Abrams

|Dec 24, 2021
Sodium-glucose cotransporter 2 inhibitors: renal outcomes according to baseline albuminuria.

Pierre Delanaye, Karl Martin Wissing, Andre J Scheen

|Dec 10, 2021
mRNA-1273 vaccine (Moderna): a better option than BNT162b2 (Pfizer) in kidney transplant recipients and dialysis patients?

Veerle P W M Wijtvliet, Kevin K Ariën, Steven Abrams

|Dec 15, 2019
Improving outcomes after renal transplantation starts well before surgery - the role of renal replacement modality.

Karl Martin Wissing, Karlien François, Lissa Pipeleers

Pageof 2